Roberto Artusi

USPTO Granted Patents = 11 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 2)

EPO Patents = 11 (Patent Applications = 10)

Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 21(Granted Patents)

Location History:

Rho Milan, IT (2006)
Monza, IT (2015)
Rho, IT (2007 - 2018)

Company Filing History:

4 out of 16

Rottapharm Biotech S.r.l.

Rotta Research Laboratorium

patents

4. 1 out of 1

Rotta Research Laboraturium S.p.a.

Years Active: 2006-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509446 - FYN and VEGFR2 kinase inhibitors (2025-12-30),

2. 12404245 - Process for the preparation of (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof (2025-09-02),

3. 10125121 - FYN kinase inhibitors (2018-11-13),

4. 9493438 - 4,4-difluoro-piperidine-compounds (2016-11-15),

5. 9062033 - Chemical compounds (2015-06-23),

6. 8372866 - 2-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain (2013-02-12),

7. 7906501 - Pyrrole derivatives with angiotensin II antagonist activity (2011-03-15),

8. 7674809 - Anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production (2010-03-09),

9. 7560591 - Benzamidine derivatives having anti-inflammatory and immunosuppressive activity (2009-07-14),

10. 7202277 - Benzamidine derivatives having anti-inflammatory and immunosuppressive activity (2007-04-10),

11. 7145037 - Adamantane derivatives with neuroprotective, antidepressant and anti-ischaemic activities, and process for preparing them (2006-12-05),

Title: The Innovative Contributions of Roberto Artusi

Introduction

Roberto Artusi is a notable inventor based in Rho, Italy, recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Artusi has made strides in developing innovative processes and compounds that have potential applications in medical treatments.

Latest Patents

Among his latest patents is a process for the preparation of (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)-cyclopropyl) benzoic acid or a salt thereof. This invention outlines a detailed method for synthesizing (R)-6-(tert-butoxycarbonyl)-6-azaspiro[2.5]octane-5-carboxylic acid, involving several chemical reactions and the use of specific reagents. Another significant patent focuses on new selective FYN kinase inhibitors, which are pharmaceutical compositions aimed at treating pain and arthritis, including osteoarthritis and rheumatoid arthritis.

Career Highlights

Artusi has worked with prominent companies such as Rottapharm Spa and Rottapharm Biotech S.r.l., where he has contributed to various research and development projects. His work has been instrumental in advancing pharmaceutical innovations that address critical health issues.

Collaborations

Throughout his career, Artusi has collaborated with esteemed colleagues, including Lucio C Rovati and Francesco Makovec. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Roberto Artusi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of new treatments, showcasing the importance of innovation in addressing health challenges.

This text is generated by artificial intelligence and may not be accurate.